期刊文献+

A20基因缺失对弥漫大B细胞淋巴瘤临床病理特征和预后的影响及相关分子机制研究 被引量:8

Impacts of A20 gene deletion on clinicopathological features and prognosis of diffuse large B cell lymphoma and relative molecular mechanism
在线阅读 下载PDF
导出
摘要 目的检测弥漫大B细胞淋巴瘤(DLBCL)中肿瘤坏死因子α诱导蛋白3基因(A20基因)缺失情况,探讨A20基因缺失对DLBCL临床过程及预后的影响及其与核因子-κB(NF-κB)通路活化的关系。方法荧光原位杂交检测其A20基因缺失情况;免疫组织化学染色检测肿瘤中A20、Survivin、P65、Ki-67蛋白的表达,TUNEL技术检测肿瘤细胞凋亡水平,收集临床病理资料并随访,进行统计分析。结果 DLBCL病例A20基因缺失率为21.7%,活化后B细胞样型(ABC)-DLBCL的A20基因缺失率明显高于生发中心B细胞样型(GCB)-DLBCL(30.6%vs.8.3%,P<0.05),A20蛋白表达与A20基因缺失呈负相关(r=-0.259,P=0.023),P65蛋白和Survivin蛋白表达与A20基因缺失呈正相关(r=0.280、0.313,P=0.015、0.007);肿瘤细胞凋亡在A20基因缺失的DLBCL病例中较低,在A20蛋白表达阳性病例中明显高于表达阴性病例,在Survivin和P65蛋白阳性表达病例中明显低于阴性表达病例(P<0.05),而在ABC-DLBCL和GCB-DLBCL病例间差异无统计学意义(P>0.05);COX回归分析结果显示,年龄、A20基因的缺失、DLBCL类型和Ki67表达是DLBCL独立的生存相关因素;A20基因缺失者的生存状况明显较未缺失者差(P=0.015)。结论 A20缺失可能影响A20蛋白表达,使其对NF-κB活化的负调节作用减弱,使Survivin表达上调而影响肿瘤细胞的增殖和凋亡;A20基因缺失对DLBCL的临床过程和预后有一定影响。 Objective To detect the A20 gene deletion,investigate the impacts of A20 gene deletion on clinicopathological features and prognosis of DLBCL, and relationship between activation of NF-κB pathway and relative molecular pathogenesis. Meth- ods A20 gene deletion was detected by fluorescence in situ hybridization (FISH). The expression of A20,Survivin,P65 and Ki-67 were detected by immunohistochemistry stain. Apoptosis was assayed by TUNEL. Follow-up and statistical analysis were done. Re- suits The deletion rate of A20 gene was 21.7%. The deletion rate of A20 gene was obviously higher in ABC-like DLBCL than that in GCB-like DLBCL (30.6% vs. 8.3% ,P〈O. 05). It was observed that there was a negative correlation between A20 protein ex- pression and A20 gene deletion (r=-0. 259 ,P=0. 023). The expression of P65 and Survivin protein was positively correlated with the A20 gene deletion (r= 0. 280, P = 0. 015 ; r= 0. 313, P = 0. 007). Apoptosis rate was significantly reduced in DLBCL patients with A20 gene deletion. The apoptosis rate was higher in cases with positive expression of A20 protein,while that was lower in ca- ses with positive expression of p65 and Survivin protein than those with negative expression of corresponding protein. There was no statistically significant difference in apoptosis rate between ABC-like and GCB-like DLBCL patients (P~〉0.05). COX regression a- naiysis indicated that age, A20 gene deletion, types of DLBCL and Ki67 expression were independent factors associated with survival status. Log-rank test showed that there was a statistical difference in survival status between the cases with and without A20 gene deletion (P=0. 015). Conclusion A20 gene deletion may associate with the attenuation of A20 protein expression. The latter weak- ens negative feedback regulation of A20 protein for NF-κB pathway. An up-regulated expression of Survivin and abnormal prolifera- tion and apoptosis may be result from the abnormal activation of NF-κB. A20 gene deletion brings certain influence on clinical course and prognosis of DLBCL.
出处 《重庆医学》 CAS 北大核心 2017年第19期2594-2598,共5页 Chongqing medicine
基金 国家自然科学基金资助项目(NO.81160299)
关键词 淋巴瘤 A20基因 NF-κB SURVIVIN 预后 基因缺失 lymphoma A20 gene NF-κB Survivin prognosis gene deletion
  • 相关文献

参考文献3

二级参考文献39

  • 1王漪,刘心,张海涛,余敏,王晖.白血病细胞中NF-κB调控MDR1基因、P糖蛋白及逆转耐药的研究[J].中国实验血液学杂志,2007,15(5):950-954. 被引量:12
  • 2张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2008.232-235.
  • 3Sweredlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue[M]. IARC Press. 4th Edition, 2008: 214-217, 233-237.
  • 4Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 func- tions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas[J]. Blood, 2009, 114(12):2467-2475.
  • 5Hirsch B, Grunbaum M, Wagner F, et al. A novel A20 (TN- FAIP3) antibody (Bet--A20) can be used to detect unmutated A20 by immunohistology[J]. Histopathology, 2012, 60(6B):E19- E27.
  • 6Compagno M, Lira WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-ceU lymphoma[J]. Nature, 2009, 459(7247):717-721.
  • 7Liu F, Karube K, Kato H, et al. Mutation analysis of NF-KB sig- nal pathway--related genes in ocular MALT lymphoma[J]. Clin Exp Pathol, 2012, 5 (5):436-441.
  • 8MarteIli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol, 2013, 87(2):146-171.
  • 9Bosanac I, Wertz IE, Pan B, et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling[J]. Mol Cell, 2010, 40(4):548-557.
  • 10Sarah G, Hymowitz, Iogrid E, et al. A20 from ubiquitin editing to- tumour suppression[J]. Nature, 2010, 10(5):332-340.

共引文献17

同被引文献49

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部